Bone morphogenetic protein 2 inhibits growth differentiation factor 8-induced cell signaling via upregulation of gremlin2 expression in human granulosa-lutein cells
Open Access
- 27 November 2021
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 19 (1) , 1-16
Abstract
Background: Bone morphogenetic protein 2 (BMP2), growth differentiation factor 8 (GDF8) and their functional receptors are expressed in human ovarian follicles, and these two intrafollicular factors play essential roles in regulating follicle development and luteal function. As BMP antagonists, gremlin1 (GREM1) and gremlin2 (GREM2) suppress BMP signaling through blockage of ligand-receptor binding. However, whether BMP2 regulates the expression of GREM1 and GREM2 in follicular development remains to be determined. Methods: In the present study, we investigated the effect of BMP2 on the expression of GREM1 and GREM2 and the underlying mechanisms in human granulosa-lutein (hGL) cells. An established immortalized human granulosa cell line (SVOG) and primary hGL cells were used as study models. The expression of GREM1 and GREM2 were examined following cell incubation with BMP2 at different concentrations and time courses. The TGF-β type I inhibitors (dorsomorphin, DMH-1 and SB431542) and small interfering RNAs targeting ALK2, ALK3, SMAD2/3, SMAD1/5/8 and SMAD4 were used to investigate the involvement of the SMAD-dependent pathway. Results: Our results showed that BMP2 significantly increased the expression of GREM2 (but not GREM1) in a dose- and time-dependent manner. Using a dual inhibition approach combining kinase inhibitors and siRNA-mediated knockdown, we found that the BMP2-induced upregulation of GREM2 expression was mediated by the ALK2/3-SMAD1/5-SMAD4 signaling pathway. Moreover, we demonstrated that BMP2 pretreatment significantly attenuated the GDF8-induced phosphorylation of SMAD2 and SMAD3, and this suppressive effect was reversed by knocking down GREM2 expression. Conclusions: Our findings provide new insight into the molecular mechanisms by which BMP2 modulates the cellular activity induced by GDF8 through the upregulated expression of their antagonist (GREM2).Keywords
Funding Information
- Canadian Institutes of Health Research (143317)
- The National Key R&D Program of China (2019YFA0110900)
- The International (Regional) Cooperation and Exchange Project (81820108016)
This publication has 51 references indexed in Scilit:
- Antimüllerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cellsFertility and Sterility, 2013
- Bone morphogenetic protein 7 suppresses the progression of hepatic fibrosis and regulates the expression of gremlin and transforming growth factor β1Molecular Medicine Reports, 2012
- Impaired Gremlin 1 (GREM1) expression in cumulus cells in young women with diminished ovarian reserve (DOR)Journal of Assisted Reproduction and Genetics, 2011
- Loss of Gremlin Delays Primordial Follicle Assembly but Does Not Affect Female Fertility in Mice1Biology of Reproduction, 2011
- Elevated levels of gremlin-1 in eutopic endometrium and peripheral serum in patients with endometriosisFertility and Sterility, 2009
- Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitroExperimental Cell Research, 2009
- Regulation of granulosa and theca cell transcriptomes during ovarian antral follicle developmentMolecular Reproduction and Development, 2008
- Protein Related to DAN and Cerberus Is a Bone Morphogenetic Protein Antagonist That Participates in Ovarian Paracrine RegulationJournal of Biological Chemistry, 2004
- Divergence and convergence of TGF‐β/BMP signalingJournal of Cellular Physiology, 2001
- Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigenMolecular and Cellular Endocrinology, 1996